Dayna Lesueur

Dayna LeSueur is the associate director, of regulatory affairs at Verve Therapeutics. She has over 6 years of experience in drug development, within the life sciences industry, and has held a number of positions in areas such as regulatory strategy, clinical development, and medical affairs. Dayna has worked across multiple therapeutic areas, including adult and pediatric rare diseases, hematology, endocrinology, and immuno-oncology. She has supported several successful marketing approvals, including the siRNA therapeutic OXLUMO (lumasiran), and has, most recently, been supporting the early development of several investigational gene therapies and CAR-T cell therapies. Prior to joining Verve, Dayna worked at CRISPR Therapeutics and Alnylam Pharmaceuticals. Dayna earned her Doctor of Pharmacy (Pharm.D.) and M.S. in regulatory affairs for drugs, biologics, and medical devices from Northeastern University. She completed her postdoctoral fellowship in regulatory strategy at Alnylam Pharmaceuticals, in the Northeastern University Pharmaceutical Industry Fellowship Program.